Vivo Capital, LLC Insmed Inc Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $11.3 Million - $23.5 Million	800,000 New	800,000 $19.5 Million
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $27.1 Million - $45.1 Million	-1,748,174 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$23.0 - $32.19 $13.3 Million - $18.6 Million	577,884 Added 49.38%	1,748,174 $44.8 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $16.3 Million - $36.5 Million	1,170,290 New	1,170,290 $34 Million

498

189M

3.21M

2.72M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.8B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.